Pharmacotherapy treatment of stimulant use disorder
Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment modality for SUDs and no pharmacotherapy is curr...
Κύριος συγγραφέας: | Mei T. Liu, PharmD, BCPP |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
American Association of Psychiatric Pharmacists
2021-11-01
|
Σειρά: | Mental Health Clinician |
Θέματα: | |
Διαθέσιμο Online: | https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.347 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Transcranial Stimulation for the Treatment of Stimulant Use Disorder
ανά: Amber N. Edinoff, κ.ά.
Έκδοση: (2023-02-01) -
A preliminary evaluation of N-acetylcysteine's effects on patient adherence to treatment for cocaine use disorder
ανά: Jake Schechter, DNP, PMHNP-BC, RN, κ.ά.
Έκδοση: (2023-03-01) -
Psychostimulants and social behaviors
ανά: Valeska Cid-Jofré, κ.ά.
Έκδοση: (2024-04-01) -
Preventing overdoses involving stimulants: the POINTS study protocol
ανά: Jaclyn M. W. Hughto, κ.ά.
Έκδοση: (2024-08-01) -
Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review
ανά: Jaya Kumar, κ.ά.
Έκδοση: (2024-07-01)